ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy.

@article{Morgan2016ALternateSC,
  title={ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy.},
  author={John M. Morgan and Mauro Biffi and Laszlo Geller and Christophe Leclercq and Franco Ruffa and Stanley K K Tung and Pascal Defaye and Zhongping Yang and Bart Gerritse and Mireille M.E. van Ginneken and Raymond Yee and Pierre Jais},
  journal={European heart journal},
  year={2016},
  volume={37 27},
  pages={
          2118-27
        }
}
AIMS The ALternate Site Cardiac ResYNChronization (ALSYNC) study evaluated the feasibility and safety of left ventricular endocardial pacing (LVEP) using a market-released pacing lead implanted via a single pectoral access by a novel atrial transseptal lead delivery system. METHODS AND RESULTS ALSYNC was a prospective clinical investigation with a minimum of 12-month follow-up in 18 centres of cardiac resynchronization therapy (CRT)-indicated patients, who had failed or were unsuitable for… CONTINUE READING
Tweets
This paper has been referenced on Twitter 11 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES

Similar Papers

Loading similar papers…